Irritable bowel syndrome: low dose antidepressant improves symptoms.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 38692664.
- Also identified by DOI 10.1136/bmj.q871.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The studyFord AC, Wright-Hughes A, Alderson SL, et al. Amitriptyline at low-dose and titrated for irritable bowel syndrome as second-line treatment in primary care (ATLANTIS): a randomised, double-blind, placebo-controlled, phase 3 trial. <i>Lancet</i> 2023;402:1773-85.To read the full NIHR Alert, go to: https://evidence.nihr.ac.uk/alert/irritable-bowel-syndrome-low-dose-antidepressant-improves-symptoms/.
Medical subject headings
- Irritable Bowel Syndrome
- Amitriptyline